Cargando…
FGF21 does not require interscapular brown adipose tissue and improves liver metabolic profile in animal models of obesity and insulin-resistance
FGF21 is a key metabolic regulator modulating physiological processes and its pharmacological administration improves metabolic profile in preclinical species and humans. We used native-FGF21 and a long-acting FGF21 (PF-05231023), to determine the contribution of liver and brown adipose tissue (BAT)...
Autores principales: | Bernardo, Barbara, Lu, Min, Bandyopadhyay, Gautam, Li, Pingping, Zhou, Yingjiang, Huang, Jie, Levin, Nancy, Tomas, Eva M., Calle, Roberto A., Erion, Derek M., Rolph, Timothy P., Brenner, Martin, Talukdar, Saswata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4495598/ https://www.ncbi.nlm.nih.gov/pubmed/26153793 http://dx.doi.org/10.1038/srep11382 |
Ejemplares similares
-
Cerenkov Luminescence Imaging of Interscapular Brown Adipose Tissue
por: Zhang, Xueli, et al.
Publicado: (2014) -
Sympathetic innervation of the interscapular brown adipose tissue in mouse
por: François, Marie, et al.
Publicado: (2019) -
FGF19 and FGF21: In NASH we trust
por: Talukdar, Saswata, et al.
Publicado: (2020) -
PF-05231023, a long-acting FGF21 analogue, decreases body weight by reduction of food intake in non-human primates
por: Thompson, W. Clayton, et al.
Publicado: (2016) -
Physical Activity Attenuates the Obesity-Induced Dysregulated Expression of Brown Adipokines in Murine Interscapular Brown Adipose Tissue
por: Sakurai, Takuya, et al.
Publicado: (2021)